Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.47 |
| ▸ | NTSR1 | P30989 | 6/20 | 0.47 |
| ▸ | NTSR2 | O95665 | 4/20 | 0.47 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24504160 | 0.90 | NTSR1 (0.48) | F2OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL24516989 | 0.89 | F2 (0.56) | F2OPRD1NTSR1NTSR2 | |
| SCHEMBL24504179 | 0.89 | F2 (0.54) | F2OPRD1NTSR1NTSR2 | |
| SCHEMBL24517136 | 0.88 | NTSR1 (0.49) | F2OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL24517139 | 0.86 | OPRD1 (0.54) | F2OPRD1NTSR1NTSR2 | |
| SCHEMBL16847816 | 0.83 | F2 (0.52) | F2OPRD1NTSR1NTSR2 | |
| SCHEMBL9058846 | 0.81 | OPRD1 (0.56) | F2OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29658852 | 0.81 | F2 (0.55) | F2OPRD1 | |
| SCHEMBL31253371 | 0.81 | OPRD1 (0.52) | F2OPRD1NTSR1NTSR2 | |
| SCHEMBL30547470 | 0.80 | OPRD1 (0.54) | OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11692007-B2 | Amino deprotection using 3-(diethylamino)propylamine | Alma Mater Studiorum—Università di Bologna (IT) | 2023-07-04 | — | — | US | disclosed |
| US-11692007-B2 | Amino deprotection using 3-(diethylamino)propylamine | Alma Mater Studiorum—Università di Bologna (IT) | 2023-07-04 | — | — | US | disclosed |
| US-20220185842-A1 | AMINO DEPROTECTION USING 3-(DIETHYLAMINO)PROPYLAMINE | Alma Mater Studiorum - Università di Bologna (IT) | 2022-06-16 | — | — | US | disclosed |
| EP-4011901-A1 | METHOD FOR THE FMOC GROUP CLEAVAGE | Fresenius Kabi iPSUM S.r.l. (IT) | 2022-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220185842-A1 | AMINO DEPROTECTION USING 3-(DIETHYLAMINO)PROPYLAMINE | PEPD, ANPEP, DNPEP | F2 1522/4885OPRD1 1918/4885NTSR1 168/4885 |
| US-11692007-B2 | Amino deprotection using 3-(diethylamino)propylamine | PEPD, ANPEP, DNPEP | F2 1522/4885OPRD1 1918/4885NTSR1 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.